Trusted by:

clients clients clients clients clients clients clients clients clients clients
Newswise: AI Speaks Volumes When It Comes to Detecting Parkinson's Disease
Released: 20-Nov-2024 8:20 PM EST
AI Speaks Volumes When It Comes to Detecting Parkinson's Disease
University of South Australia

Algorithms that can detect subtle changes in a person’s voice are emerging as a potential new diagnostic tool for Parkinson’s disease, according to researchers from Iraq and Australia.

   
Newswise:Video Embedded synchronised-movement-between-robots-and-humans-builds-trust-study-finds
VIDEO
18-Nov-2024 6:35 AM EST
Synchronised Movement Between Robots and Humans Builds Trust, Study Finds
University of Bristol

Trust between humans and robots is improved when the movement between both is harmonised, researchers have discovered.

Release date: 20-Nov-2024 4:55 PM EST
Argonne plays critical role in assessing small modular reactor applications to rebuild a clean economy in post-war Ukraine
Argonne National Laboratory

Small modular reactors could play key role in rebuilding a clean economy in post-war Ukraine. Argonne scientists will assess the emerging technology in new research.

Released: 20-Nov-2024 4:25 PM EST
In the ‘Wild West’ of AI Chatbots, Subtle Biases Related to Race and Caste Often Go Unchecked
University of Washington

University of Washington researchers developed a system for detecting subtle biases in AI models. They found seven of the eight popular AI models they tested in conversations around race and caste generated significant amounts of biased text in interactions — particularly when discussing caste. Open-source models fared far worse than two proprietary ChatGPT models.

Release date: 20-Nov-2024 4:15 PM EST
Breaking research could help to advance care for overdose patients who’ve taken xylazine
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A novel study published today in ADLM’s journal, Clinical Chemistry, has found that it takes the human body much longer than previously thought to clear xylazine — one of the most popular emerging drugs of abuse in the U.S. This much-needed insight into how the body processes xylazine could improve treatment of overdose patients who’ve taken it.

Newswise: Study: Innovative light technology is safe, effective for mitigating fungal contamination of cereal grains
Release date: 20-Nov-2024 4:10 PM EST
Study: Innovative light technology is safe, effective for mitigating fungal contamination of cereal grains
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

In a new study, researchers at the University of Illinois Urbana-Champaign evaluated far-ultraviolet C (far-UVC) light as a safe way to alleviate fungal contamination of corn and wheat and found this technology to be effective.

Newswise: Scientists Compare Throughput for Quantum vs. Conventional Networks
Released: 20-Nov-2024 4:05 PM EST
Scientists Compare Throughput for Quantum vs. Conventional Networks
Department of Energy, Office of Science

Entangled quantum bits per second (ebps) indicates a quantum network’s throughput. In this study, researchers collected ebps measurements over a suite of fiber connections on a quantum network testbed. They then compared these measurements with capacity estimates for a conventional fiber-optic network at a range of distances. The study finds that ebps throughput decays sharply with distance in ways that differ from conventional networks.

15-Nov-2024 3:50 PM EST
How Long Does It Take to Recover from “Brain on Fire” Disorder?
American Academy of Neurology (AAN)

Recovery from an autoimmune inflammation of the brain may take three years or more, according to a study published in the November 20, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

15-Nov-2024 3:40 PM EST
Study Finds Disparities in Telemedicine Use for Neurological Conditions
American Academy of Neurology (AAN)

For people seeing a neurologist, their age, race, ethnicity and neighborhood may play a role in whether they do so in person or virtually, via telemedicine, according to a study published in the November 20, 2024, online issue of Neurology® Clinical Practice , an official journal of the American Academy of Neurology.

Released: 20-Nov-2024 3:45 PM EST
More Than Half of U.S. Adults Could Benefit From GLP-1 Medications, Researchers Find
Beth Israel Lahey Health

In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) estimated that 137 million U.S. adults, more than half of all adults, are eligible for semagludtide for weight loss, diabetes management, or prevention of recurrent cardiovascular events.


close
1.67787